As part of the deal, KKR will purchase up to 54 per cent of HCG's equity from CVC Asia V at a price of INR 445 per share.

US-based investment company KKR has agreed to acquire a stake of up to 54% in Healthcare Global Enterprises (HCG), an oncology hospital chain in India, for $400m. KKR will acquire the stake in HCG from global private markets manager CVC Asia V at a rate of Rs445 ($5.

As part of the transaction, KKR will acquire up to 54 per cent of equity in HCG from CVC Asia V at a purchase price of Rs 445 per share

Boosted by the development, Healthcare Global shares rose 3.5% to ₹517.85 in early trade today, while the market capitalisation climbed to ₹7,175 crore. The healthcare stock opened higher at ₹502.15 against Friday’s closing price of ₹500 apiece.

American private equity fund KKR will acquire a 51% stake in HealthCare Global Enterprises for Rs 3,203 crore, making an open offer for an additional

As part of the transaction, KKR will acquire up to 54 per cent of equity in HCG from CVC Asia V at a purchase price of Rs 445 per share

US private equity firm KKR & Co. will acquire a majority stake in HealthCare Global Enterprises Ltd. for around Rs 3,350 crore.

KKR said it has agreed to acquire a controlling stake in cancer treatment chain HealthCare Global Enterprises Ltd (HCG) from fellow private equity firm CVC for ₹445 per share, amounting to around $400 million.